An update on our CRD-TMH-001 clinical trial

As we’ve communicated to the CRD and scientific communities, a team of researchers and clinicians led by Yale University and UMass Chan Medical School has been studying what happened to Terry. We wanted to provide an update that their study will be published on the pre-print server within the next three weeks.

Our focus has been on getting the best learnings we can from Terry’s outcome and sharing those learnings for the benefit of the entire scientific community, and we thank you for your patience during this important process.